Overview
Infantile fibrosarcoma is a rare soft tissue sarcoma predominantly affecting infants under one year of age, characterized by aggressive local behavior and potential for early metastasis despite its relatively favorable prognosis compared to other pediatric sarcomas 12.Diagnosis
Clinical Presentation: May present with localized mass, pain, or functional deficits (e.g., drop foot, immobility) 2.
Imaging: MRI is crucial for assessing tumor extent and local invasion 2.
Biopsy: Fine-needle aspiration or core needle biopsy confirms diagnosis 2.
Radiographic Findings: Metastasis can occur in unusual sites such as the heart and lungs 1.Management
First-Line Treatment: Chemotherapy regimens typically include vincristine, actinomycin-D, and cyclophosphamide 2.
Surgical Resection: Essential for primary tumor removal when feasible 1.
Supportive Care: Monitor for complications like veno-occlusive disease of the liver 2.Special Populations
Pediatrics: Aggressive monitoring and early intervention are critical due to rapid progression 12.
Comorbidities: Increased vigilance for rare complications such as cardiac metastasis and hypertrophic osteoarthropathy 1.Key Recommendations
Early and thorough imaging including MRI to assess extent and potential metastasis (Evidence: Moderate 2).
Initiate aggressive chemotherapy with regimens including vincristine, actinomycin-D, and cyclophosphamide (Evidence: Weak 2).
Surgical intervention should be considered for primary tumor resection when possible (Evidence: Expert opinion 1).
Closely monitor for rare complications such as cardiac involvement and hepatic toxicity (Evidence: Expert opinion 12).References
1 Shah NN, Price MR, Loeb DM. Cardiac metastasis and hypertrophic osteoarthropathy in recurrent infantile fibrosarcoma. Pediatric blood & cancer 2012. link
2 Gülhan B, Küpeli S, Yalçin B, Akyüz C, Büyükpamukçu M. An unusual presentation of infantile fibrosarcoma in a male newborn. American journal of perinatology 2009. link